Investor Relations

Press Releases


Press Releases

Date Title  
November 24, 2020 Fulgent Genetics to Participate in the Piper Sandler 32nd Annual Healthcare Conference
November 23, 2020 Fulgent Genetics Announces Increase to Full Year 2020 Guidance to $300 million
November 10, 2020 Fulgent Genetics to Participate in the Credit Suisse 29th Annual Virtual Healthcare Conference
November 9, 2020 Fulgent Genetics Reports Record Third Quarter 2020 Financial Results and Raises Full Year 2020 Revenue Guidance by $100 Million
October 26, 2020 Fulgent Genetics to Announce Third Quarter 2020 Financial Results on Monday November 9, 2020
September 30, 2020 Fulgent Genetics Announces Partnership with Ohio Department of Rehabilitation and Correction for COVID-19 Testing
September 30, 2020 Pac-12 adds to RT-PCR COVID-19 testing capabilities with Fulgent Genetics Partnership
September 15, 2020 Fulgent Genetics to Provide COVID-19 Testing Solutions for the State of Utah
September 9, 2020 Fulgent Genetics, Miami-Dade County Partner on COVID-19 testing
September 4, 2020 Fulgent Genetics to Participate in the H.C. Wainwright 22nd Annual Global Investment Conference
September 3, 2020 Fulgent Genetics Adds Influenza A and Influenza B to all COVID-19 Tests
September 2, 2020 Fulgent Genetics, New York City Health and Hospitals Partner on Large-Scale Back-to-School COVID-19 Testing
August 17, 2020 Fulgent Genetics Announces Expansion into Houston, TX
August 4, 2020 Fulgent Genetics Reports Record Second Quarter 2020 Financial Results
July 14, 2020 Fulgent Genetics to Announce Second Quarter 2020 Financial Results on Tuesday August 4, 2020
June 16, 2020 Fulgent Genetics Announces FDA Authorization and Launch of At-Home Testing Service for COVID-19
May 18, 2020 Fulgent Genetics Receives Emergency Use Authorization from the FDA for its RT-PCR Test for Detection of SARS-CoV-2, the Virus that Causes COVID-19
May 4, 2020 Fulgent Genetics Reports First Quarter 2020 Financial Results
April 9, 2020 Fulgent Genetics to Announce First Quarter 2020 Financial Results on Monday May 4, 2020
April 9, 2020 Fulgent Genetics Provides Update on Testing for COVID-19
March 17, 2020 Fulgent Genetics Announces Launch of Next Generation Sequencing (NGS) Test to Detect Coronavirus Disease (COVID-19)
March 10, 2020 Fulgent Genetics Reports Fourth Quarter and Full Year 2019 Financial Results
March 10, 2020 Fulgent Genetics Announces Promotion of Brandon Perthuis to Chief Commercial Officer
February 20, 2020 Fulgent Genetics to Announce Fourth Quarter and Full Year 2019 Financial Results on Tuesday March 10, 2020